Page last updated: 2024-08-26

4-hydroxydebrisoquin and Cancer of Lung

4-hydroxydebrisoquin has been researched along with Cancer of Lung in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Biola Mabadeje, AF; Boobis, AR; Davies, DS; Murray, S; Speirs, CJ1
Ayesh, R; Bale, S; Caporaso, N; Hetzel, M; Idle, J; Pickle, LW1

Other Studies

2 other study(ies) available for 4-hydroxydebrisoquin and Cancer of Lung

ArticleYear
Debrisoquine oxidation phenotype and susceptibility to lung cancer.
    British journal of clinical pharmacology, 1990, Volume: 29, Issue:1

    Topics: Adenocarcinoma; Aged; Aged, 80 and over; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Debrisoquin; Female; Humans; Isoquinolines; Lung Neoplasms; Male; Middle Aged; Oxidation-Reduction; Phenotype; Risk; Smoking

1990
The distribution of debrisoquine metabolic phenotypes and implications for the suggested association with lung cancer risk.
    Genetic epidemiology, 1989, Volume: 6, Issue:4

    Topics: Chromatography, Gas; Data Interpretation, Statistical; Debrisoquin; Gene Frequency; Genetic Predisposition to Disease; Humans; Isoquinolines; Lung Neoplasms; Phenotype; Risk Factors

1989